Breaking News, Financial News

Financial Report: Allergan

Revenues up 11% driven by Botox

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Allergan   2Q Revenues: $1.6 billion (+11%) 2Q Earnings: $361.2 million (+22%) YTD Revenues: $3.1 billion (+9%) YTD Earnings: $375.6 million (earnings were $527.6 million YTD12) Comments: Specialty pharmaceuticals sales increased 11% to $1.3 billion in the quarter, driven by Botox/Neuromodulator sales (+11% to $513 million) and skin care (+39% to $112.3 million). Medical devices sales increased 7% to $229.3 million. YTD results include a loss of $251.4 million for discontinued operations....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters